New drug halts spread of antibiotic-resistant bacteria in tests

Researchers have developed a treatment that blocks carbapenem-resistant bacteria, some of the most dangerous drug-resistant pathogens threatening hospitals worldwide. The findings, validated in both laboratory and animal models, could offer a lifeline for infections that currently have few treatment options and drive up healthcare costs significantly.

Originaltitel: In Vitro and In Vivo Development of a β-Lactam-Metallo-β- Lactamase Inhibitor: Targeting Carbapenem-Resistant Enterobacterales